Hepatitis C treatments don't seem to work as well in African Americans

Hepatitis C treatments don't seem to work as well in African Americans as in other groups...for hepatitis C virus (HCV) genotype 1.

Peginterferon alfa-2b (PEG-Intron) and ribavirin (Rebetol) are effective for HCV genotype 1 in 52% of whites...but only in 19% of African Americans.

Researchers used to think the difference in effectiveness was due to the treatment-resistant HCV genotype 1 that's more common in African Americans. But now research shows that the poor response is not explained by HCV genotype.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote